iClinic
ActiveSummary
iClinic has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.12M and a net result of €382k. Equity is growing by ~22.8% per year across the filed fiscal years. Its solvency ranks better than 63% of 2344 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100▲+5
Solvency99▼-1
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €100k at 30 days acceptable
Liquidity ample (current ratio 3.4 against 5.4 in 2024; short-term debt: 26.1% and cash: 28.6% of total assets), and 26.1% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
73.9%
Return on assets
25.2%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
32 d early
2024
28 d late
2023
28 d late
2022
30 d late
2021
25 d late
2020
30 d late
2019
61 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€1.12M▼ 19.2%
2024 · €1.38M
2018: €360klowest in 8 years
2019: €504k▲ +39.9% vs 2018
2020: €536k▲ +6.4% vs 2019
2021: €672k▲ +25.4% vs 2020
2022: €978k▲ +45.4% vs 2021
2023: €1.18M▲ +20.7% vs 2022
2024: €1.38M▲ +17.2% vs 2023highest in 8 years
2025: €1.12M▼ -19.2% vs 2024
2018 → 2025
Total assets
€1.51M▼ 8.8%
2024 · €1.66M
2018: €387klowest in 8 years
2019: €531k▲ +37.2% vs 2018
2020: €575k▲ +8.2% vs 2019
2021: €736k▲ +28.1% vs 2020
2022: €1.11M▲ +50.8% vs 2021
2023: €1.31M▲ +17.9% vs 2022
2024: €1.66M▲ +26.7% vs 2023highest in 8 years
2025: €1.51M▼ -8.8% vs 2024
2018 → 2025
Net result
€382k▲ 10.0%
2024 · €347k
2018: €78klowest in 8 years
2019: €144k▲ +84.9% vs 2018
2020: €112k▼ -22.0% vs 2019
2021: €207k▲ +85.0% vs 2020
2022: €328k▲ +58.3% vs 2021
2023: €280k▼ -14.7% vs 2022
2024: €347k▲ +24.0% vs 2023
2025: €382k▲ +10.0% vs 2024highest in 8 years
2018 → 2025
Working capital
€950k▼ 21.8%
2024 · €1.21M
2018: €258klowest in 8 years
2019: €432k▲ +67.7% vs 2018
2020: €499k▲ +15.6% vs 2019
2021: €591k▲ +18.3% vs 2020
2022: €923k▲ +56.3% vs 2021
2023: €1.13M▲ +22.7% vs 2022
2024: €1.21M▲ +7.2% vs 2023highest in 8 years
2025: €950k▼ -21.8% vs 2024
2018 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€672k-€978k▲ 45.4%€1.18M▲ 20.7%€1.38M▲ 17.2%€1.12M▼ 19.2%
2021: €672klowest in 5 years
2022: €978k▲ +45.4% vs 2021
2023: €1.18M▲ +20.7% vs 2022
2024: €1.38M▲ +17.2% vs 2023highest in 5 years
2025: €1.12M▼ -19.2% vs 2024
Operating result€297k-€477k▲ 60.7%€406k▼ 14.9%€482k▲ 18.8%€539k▲ 11.9%
2021: €297klowest in 5 years
2022: €477k▲ +60.7% vs 2021
2023: €406k▼ -14.9% vs 2022
2024: €482k▲ +18.8% vs 2023
2025: €539k▲ +11.9% vs 2024highest in 5 years
Net result€207k-€328k▲ 58.3%€280k▼ 14.7%€347k▲ 24.0%€382k▲ 10.0%
2021: €207klowest in 5 years
2022: €328k▲ +58.3% vs 2021
2023: €280k▼ -14.7% vs 2022
2024: €347k▲ +24.0% vs 2023
2025: €382k▲ +10.0% vs 2024highest in 5 years
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 12% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.51M
Fixed assets
€168k ▼ 0.6%
Current assets
€1.35M ▼ 9.8%
Equity and liabilities €1.51M
Equity
€1.12M ▼ 19.2%
Debt
€395k ▲ 43.2%
Debt's share of the balance-sheet total rises from 16.6% to 26.1%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€573k▲
2024 · €504k
Cash flow
€416k▲
2024 · €370k
Current ratio
3.40▼
2024 · 5.40
Debt to equity
0.35▲
2024 · 0.20
ROE
34.2%▲
2024 · 25.1%
ROA
25.2%▲
2024 · 20.9%
Interest coverage
143.47▲
2024 · 137.91
Debt ≤ 1 year
€395k▲
2024 · €276k
Income taxes
€174k▲
2024 · €154k
Staff costs
€46k▼
2024 · €59k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 48 lines
Balance sheet
Code20242025
Assets
Total assets20/58€1.66M€1.51M▼
Fixed assets21/28€169k€168k▼
Tangible fixed assets22/27€169k€168k▼
Plant, machinery and equipment23€65k€80k▲
Furniture and vehicles24€104k€88k▼
Current assets29/58€1.49M€1.35M▼
Amounts receivable within one year40/41€100k€102k▲
Trade receivables40€53k€55k▲
Other amounts receivable41€46k€48k▲
Current investments50/53€1.11M€806k▼
Cash at bank and in hand54/58€280k€432k▲
Deferred charges and accrued income490/1€4k€5k▲
Equity and liabilities
Total equity and liabilities10/49€1.66M€1.51M▼
Equity10/15€1.38M€1.12M▼
Contributions10/11€28k€28k=
Reserves13€1.28M€1.01M▼
Distributable reserves133€1.28M€1.01M▼
Profit (loss) carried forward14€78k€78k=
Amounts payable17/49€276k€395k▲
Amounts payable within one year42/48€276k€395k▲
Trade debts44€83k€18k▼
Suppliers440/4€83k€18k▼
Taxes, remuneration and social security45€48k€45k▼
Taxes450/3€43k€42k▼
Remuneration and social security454/9€4k€3k▼
Other amounts payable47/48€145k€332k▲
Income statement
Code20242025
Remuneration, social security and pensions62€59k€46k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€22k€34k▲
Other operating charges640/8€968€998▲
Non-recurring operating charges66A€445€476▲
Gross operating margin9900€564k€621k▲
Operating profit (loss)9901€482k€539k▲
Financial income75/76B€24k€21k▼
Recurring financial income75€24k€21k▼
Financial charges65/66B€4k€4k▲
Recurring financial charges65€4k€4k▲
Profit (loss) for the period before taxes9903€502k€555k▲
Income taxes67/77€154k€174k▲
Profit (loss) for the period9904€347k€382k▲
Profit (loss) for the period to be appropriated9905€347k€382k▲
Appropriation of the result
Profit (loss) to be appropriated9906€425k€460k▲
Profit (loss) brought forward from the previous period14P€78k€78k=
Transfer from equity791/2€144k€648k▲
Transfer to equity691/2€347k€382k▲
To other reserves6921€347k€382k▲
Profit to be distributed694/7€144k€648k▲
Return on contributions (dividend)694€144k€648k▲
Social balance
Average headcount (FTE)9087-1.2
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | €30k | €28k | €45k | €59k | €46k | ▼ 20.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €24k | €28k | €22k | €22k | €34k | ▲ 50.8% |
| Other operating charges640/8 | €348 | €348 | €384 | €968 | €998 | ▲ 3.2% |
| Non-recurring operating charges66A | €183 | €62 | €407 | €445 | €476 | ▲ 7.0% |
| Gross operating margin9900 | €352k | €534k | €473k | €564k | €621k | ▲ 10.0% |
| Operating profit (loss)9901 | €297k | €477k | €406k | €482k | €539k | ▲ 11.9% |
| Financial income75/76B | €3k | €2k | €3k | €24k | €21k | ▼ 12.8% |
| Recurring financial income75 | €3k | €2k | €3k | €24k | €21k | ▼ 12.8% |
| Financial charges65/66B | €2k | €2k | €2k | €4k | €4k | ▲ 9.2% |
| Recurring financial charges65 | €2k | €2k | €2k | €4k | €4k | ▲ 9.2% |
| Profit (loss) for the period before taxes9903 | €298k | €477k | €407k | €502k | €555k | ▲ 10.8% |
| Income taxes67/77 | €90k | €149k | €127k | €154k | €174k | ▲ 12.4% |
| Profit (loss) for the period9904 | €207k | €328k | €280k | €347k | €382k | ▲ 10.0% |
| Profit (loss) for the period to be appropriated9905 | €207k | €328k | €280k | €347k | €382k | ▲ 10.0% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €736k | €1.11M | €1.31M | €1.66M | €1.51M | ▼ 8.8% |
| Fixed assets21/28 | €82k | €55k | €47k | €169k | €168k | ▼ 0.6% |
| Tangible fixed assets22/27 | €82k | €55k | €47k | €169k | €168k | ▼ 0.6% |
| Plant, machinery and equipment23 | €9k | €5k | €4k | €65k | €80k | ▲ 22.7% |
| Furniture and vehicles24 | €72k | €50k | €43k | €104k | €88k | ▼ 15.2% |
| Current assets29/58 | €655k | €1.06M | €1.26M | €1.49M | €1.35M | ▼ 9.8% |
| Amounts receivable within one year40/41 | €122k | €91k | €115k | €100k | €102k | ▲ 2.7% |
| Trade receivables40 | €55k | €48k | €49k | €53k | €55k | ▲ 2.2% |
| Other amounts receivable41 | €67k | €43k | €66k | €46k | €48k | ▲ 3.3% |
| Current investments50/53 | - | - | €898k | €1.11M | €806k | ▼ 27.2% |
| Cash at bank and in hand54/58 | €527k | €960k | €246k | €280k | €432k | ▲ 54.5% |
| Deferred charges and accrued income490/1 | €5k | €5k | €4k | €4k | €5k | ▲ 6.6% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €736k | €1.11M | €1.31M | €1.66M | €1.51M | ▼ 8.8% |
| Equity10/15 | €672k | €978k | €1.18M | €1.38M | €1.12M | ▼ 19.2% |
| Contributions10/11 | €28k | €28k | €28k | €28k | €28k | = |
| Reserves13 | €567k | €872k | €1.07M | €1.28M | €1.01M | ▼ 20.8% |
| Non-distributable reserves130/1 | €3k | €3k | - | - | - | - |
| Reserves not available under the articles1311 | €3k | €3k | - | - | - | - |
| Distributable reserves133 | €564k | €869k | €1.07M | €1.28M | €1.01M | ▼ 20.8% |
| Profit (loss) carried forward14 | €78k | €78k | €78k | €78k | €78k | = |
| Amounts payable17/49 | €64k | €132k | €129k | €276k | €395k | ▲ 43.2% |
| Amounts payable within one year42/48 | €64k | €132k | €129k | €276k | €395k | ▲ 43.2% |
| Trade debts44 | €14k | €10k | €14k | €83k | €18k | ▼ 78.7% |
| Suppliers440/4 | €14k | €10k | €14k | €83k | €18k | ▼ 78.7% |
| Taxes, remuneration and social security45 | €50k | €79k | €36k | €48k | €45k | ▼ 4.6% |
| Taxes450/3 | €45k | €75k | €30k | €43k | €42k | ▼ 2.5% |
| Remuneration and social security454/9 | €4k | €4k | €6k | €4k | €3k | ▼ 25.5% |
| Other amounts payable47/48 | - | €43k | €79k | €145k | €332k | ▲ 129% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €207k | €328k | €280k | €347k | €382k | ▲ 10.0% |
| + Depreciation and write-downs630 | €24k | €28k | €22k | €22k | €34k | ▲ 50.8% |
| Operating cash flow (approximation) | €232k | €356k | €302k | €370k | €416k | ▲ 12.5% |
| Investment in fixed assets (approximation) | - | €-1k | €-14k | €-145k | €-33k | ▲ 77.3% |
| Change in cash | - | €432k | €-714k | €34k | €152k | ▲ 349% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
29-06
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Highest result since 2018net €382k ▲10%
Operating result €539k, net result €382k, both a record.
28-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 28 days late
2024
28-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 28 days late
2023
31-12
Financial
Equity above €1MEq €1.18M ▲20.7%
6 profitable years in a row build equity to €1.18M.
30-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 30 days late
2022
25-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 25 days late
2021
30-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 30 days late
2020
30-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 61 days late
2019
31-12
Financial
Equity above €500kEq €504k ▲39.9%
2 profitable years in a row build equity to €504k.
31-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
27-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 27 days late
2017
28-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 28 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ukkel · 1 establishment unit since 2010
Ground area
1.3 ha
Building footprint
850 m²
Volume, LiDAR
14,866 m³
2 parcels, Brussels · tallest building 24.1 m, ±7 floors. Linked by address, not a title deed.
6
companies at this address
See who is registered here
1 establishment unit
iClinic
since 20102.194.944.011
2 parcels
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21618B0265/00H002 | Brussels | 1.2 ha | 1 · 650 m² | 24.1 m · 7 fl. |
| 21612D0025/00T022 | Brussels | 1,737 m² | 1 · 200 m² | 10.1 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
549300TM6QU84DQYN375
Similar companies · same sector, comparable size
ORTHOFACE
BE 0892.661.801
Sint-Martens-Latem · Eq €1,116,690
DOKTER VANDEN BOER STIJN
BE 0840.515.193
Lommel · Eq €1,119,353
DR. MANU MALBRAIN
BE 0473.645.852
Bierbeek · Eq €1,119,551
DOCTEUR MATHIEU PIERRE-EMMANUEL
BE 0475.147.669
Saint-Ghislain · Eq €1,122,292
NEGOR
BE 0447.038.653
Braine-l'Alleud · Eq €1,123,919
Of 16,630 companies in sector 86220 we hold annual accounts for 7,979. 5,617 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded08-12-2010
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
82300Organisation of conventions and trade shows
Scores and ratios are computed by Checked and are not a credit decision.